Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive Impairment

Early detection of mild cognitive impairment (MCI) has become a priority in Alzheimer’s disease (AD) research, as it is a transitional phase between normal aging and dementia. However, information on MCI and AD is scattered across different formats and standards generated by different technologies,...

Full description

Bibliographic Details
Main Authors: Alba Gomez-Valades, Rafael Martinez-Tomas, Mariano Rincon
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Neuroinformatics
Subjects:
MCI
Online Access:https://www.frontiersin.org/articles/10.3389/fninf.2021.561691/full
id doaj-e844cd4c00de46fdb306d028b97fdd70
record_format Article
spelling doaj-e844cd4c00de46fdb306d028b97fdd702021-02-04T05:10:00ZengFrontiers Media S.A.Frontiers in Neuroinformatics1662-51962021-02-011510.3389/fninf.2021.561691561691Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive ImpairmentAlba Gomez-ValadesRafael Martinez-TomasMariano RinconEarly detection of mild cognitive impairment (MCI) has become a priority in Alzheimer’s disease (AD) research, as it is a transitional phase between normal aging and dementia. However, information on MCI and AD is scattered across different formats and standards generated by different technologies, making it difficult to work with them manually. Ontologies have emerged as a solution to this problem due to their capacity for homogenization and consensus in the representation and reuse of data. In this context, an ontology that integrates the four main domains of neurodegenerative diseases, diagnostic tests, cognitive functions, and brain areas will be of great use in research. Here, we introduce the first approach to this ontology, the Neurocognitive Integrated Ontology (NIO), which integrates the knowledge regarding neuropsychological tests (NT), AD, cognitive functions, and brain areas. This ontology enables interoperability and facilitates access to data by integrating dispersed knowledge across different disciplines, rendering it useful for other research groups. To ensure the stability and reusability of NIO, the ontology was developed following the ontology-building life cycle, integrating and expanding terms from four different reference ontologies. The usefulness of this ontology was validated through use-case scenarios.https://www.frontiersin.org/articles/10.3389/fninf.2021.561691/fullontologyMCIAlzheimer’s diseaseneuropsychological testsneurodegenerative diseaseontology design
collection DOAJ
language English
format Article
sources DOAJ
author Alba Gomez-Valades
Rafael Martinez-Tomas
Mariano Rincon
spellingShingle Alba Gomez-Valades
Rafael Martinez-Tomas
Mariano Rincon
Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive Impairment
Frontiers in Neuroinformatics
ontology
MCI
Alzheimer’s disease
neuropsychological tests
neurodegenerative disease
ontology design
author_facet Alba Gomez-Valades
Rafael Martinez-Tomas
Mariano Rincon
author_sort Alba Gomez-Valades
title Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive Impairment
title_short Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive Impairment
title_full Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive Impairment
title_fullStr Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive Impairment
title_full_unstemmed Integrative Base Ontology for the Research Analysis of Alzheimer’s Disease-Related Mild Cognitive Impairment
title_sort integrative base ontology for the research analysis of alzheimer’s disease-related mild cognitive impairment
publisher Frontiers Media S.A.
series Frontiers in Neuroinformatics
issn 1662-5196
publishDate 2021-02-01
description Early detection of mild cognitive impairment (MCI) has become a priority in Alzheimer’s disease (AD) research, as it is a transitional phase between normal aging and dementia. However, information on MCI and AD is scattered across different formats and standards generated by different technologies, making it difficult to work with them manually. Ontologies have emerged as a solution to this problem due to their capacity for homogenization and consensus in the representation and reuse of data. In this context, an ontology that integrates the four main domains of neurodegenerative diseases, diagnostic tests, cognitive functions, and brain areas will be of great use in research. Here, we introduce the first approach to this ontology, the Neurocognitive Integrated Ontology (NIO), which integrates the knowledge regarding neuropsychological tests (NT), AD, cognitive functions, and brain areas. This ontology enables interoperability and facilitates access to data by integrating dispersed knowledge across different disciplines, rendering it useful for other research groups. To ensure the stability and reusability of NIO, the ontology was developed following the ontology-building life cycle, integrating and expanding terms from four different reference ontologies. The usefulness of this ontology was validated through use-case scenarios.
topic ontology
MCI
Alzheimer’s disease
neuropsychological tests
neurodegenerative disease
ontology design
url https://www.frontiersin.org/articles/10.3389/fninf.2021.561691/full
work_keys_str_mv AT albagomezvalades integrativebaseontologyfortheresearchanalysisofalzheimersdiseaserelatedmildcognitiveimpairment
AT rafaelmartineztomas integrativebaseontologyfortheresearchanalysisofalzheimersdiseaserelatedmildcognitiveimpairment
AT marianorincon integrativebaseontologyfortheresearchanalysisofalzheimersdiseaserelatedmildcognitiveimpairment
_version_ 1724285538532327424